http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2008522955-A

Outgoing Links

Predicate Object
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-497
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P7-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-496
filingDate 2005-12-09-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 2008-07-03-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber JP-2008522955-A
titleOfInvention Lipid rich plaque reduction, stabilization and rupture prevention methods
abstract The present invention relates to 2- [4- [2- (benzimidazol-2-ylthio) ethyl] piperazin-1-yl] -N- [2,4-bis (methylthio) -6-methyl-3-pyridyl] acetamide (Hereinafter referred to as Compound 1), or a pharmaceutically acceptable salt thereof, or an effective amount of these hydrates and pitavastatin and a pharmaceutically acceptable carrier, and a patient in need thereof The present invention relates to a lipid-rich plaque reducing agent, stabilizing agent and / or rupture-preventing agent in atherosclerotic lesions for simultaneous or separate administration. In addition, the present invention also provides an effective amount of Compound 1 or a pharmaceutically acceptable salt thereof, or a hydrate thereof and an effective amount of pitavastatin to a patient in need thereof at the same time or at intervals. The present invention relates to a method for reducing, stabilizing and / or preventing rupture of lipid rich plaques in atherosclerotic lesions, which are administered separately.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011081117-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2011081118-A1
priorityDate 2004-12-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-H01279866-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9854153-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID281276
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID100683160
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID425487888
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID91506
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506440
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP07492
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458396945
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419536469
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9Y4Z0
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID395103
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP09472
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID457493196
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP9WMV9
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP13726
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP9WMV8
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID415829957
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506502
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP63153
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID42032
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP63152
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID455722
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393806
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID454185321
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID62326
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506595
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412438449
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ863C3
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP47851
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID280686
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54687
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5282452
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393705
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID16835
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP01295
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166558
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP08989
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419487268
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135403646
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419490851
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID8674055
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID412511268
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP22637
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1133
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419580517
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP12676
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID373644
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCO01945
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9892288
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ9PS30
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP31886
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCQ8R1I2
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID141311406
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID134346
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID3949
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID446156
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID43105
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5795
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID178
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID449288622
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID387529
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID35799
http://rdf.ncbi.nlm.nih.gov/pubchem/protein/ACCP24393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID408122650
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID54454
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID431899866
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22483
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID300438

Total number of triples: 88.